290 related articles for article (PubMed ID: 8343977)
41. Inhibition of cholinesterases by safranin O: Integration of inhibition kinetics with molecular docking simulations.
Onder S; Sari S; Tacal O
Arch Biochem Biophys; 2021 Feb; 698():108728. PubMed ID: 33345803
[TBL] [Abstract][Full Text] [Related]
42. Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Bosak A; Opsenica DM; Šinko G; Zlatar M; Kovarik Z
Chem Biol Interact; 2019 Aug; 308():101-109. PubMed ID: 31100281
[TBL] [Abstract][Full Text] [Related]
43. The use of cholinesterases in ecotoxicology.
Nunes B
Rev Environ Contam Toxicol; 2011; 212():29-59. PubMed ID: 21432054
[TBL] [Abstract][Full Text] [Related]
44. Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors.
Bosak A; Gazić Smilović I; Sinko G; Vinković V; Kovarik Z
J Med Chem; 2012 Aug; 55(15):6716-23. PubMed ID: 22817559
[TBL] [Abstract][Full Text] [Related]
45. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
46. Blood acetylcholinesterase and butyrylcholinesterase as biomarkers of cholinesterase depression among pesticide handlers.
Strelitz J; Engel LS; Keifer MC
Occup Environ Med; 2014 Dec; 71(12):842-7. PubMed ID: 25189163
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases.
Maraković N; Knežević A; Vinković V; Kovarik Z; Šinko G
Chem Biol Interact; 2016 Nov; 259(Pt B):122-132. PubMed ID: 27238725
[TBL] [Abstract][Full Text] [Related]
48. Time-course, dose-response, and age comparative sensitivity of N-methyl carbamates in rats.
Moser VC; McDaniel KL; Phillips PM; Lowit AB
Toxicol Sci; 2010 Mar; 114(1):113-23. PubMed ID: 19934164
[TBL] [Abstract][Full Text] [Related]
49. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
[TBL] [Abstract][Full Text] [Related]
50. A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs.
Lee S; Barron MG
J Comput Aided Mol Des; 2016 Apr; 30(4):347-63. PubMed ID: 27055524
[TBL] [Abstract][Full Text] [Related]
51. Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study.
Bak A; Kozik V; Kozakiewicz D; Gajcy K; Strub DJ; Swietlicka A; Stepankova S; Imramovsky A; Polanski J; Smolinski A; Jampilek J
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934674
[TBL] [Abstract][Full Text] [Related]
52. A retrospective screening method for carbamate toxicant exposure based on butyrylcholinesterase adducts in human plasma with ultra-high performance liquid chromatography-tandem mass spectrometry.
Ren Z; Chen B; Liang D; Liu D; Lei W; Liu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123775. PubMed ID: 37285767
[TBL] [Abstract][Full Text] [Related]
53. Comparison of acute neurobehavioral and cholinesterase inhibitory effects of N-methylcarbamates in rat.
McDaniel KL; Padilla S; Marshall RS; Phillips PM; Podhorniak L; Qian Y; Moser VC
Toxicol Sci; 2007 Aug; 98(2):552-60. PubMed ID: 17504769
[TBL] [Abstract][Full Text] [Related]
54. Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase.
Gatley SJ
Biochem Pharmacol; 1991 Apr; 41(8):1249-54. PubMed ID: 2009099
[TBL] [Abstract][Full Text] [Related]
55. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
56. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
57. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
[TBL] [Abstract][Full Text] [Related]
58. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
[TBL] [Abstract][Full Text] [Related]
59. Role of B-esterases in assessing toxicity of organophosphorus (chlorpyrifos, malathion) and carbamate (carbofuran) pesticides to Daphnia magna.
Barata C; Solayan A; Porte C
Aquat Toxicol; 2004 Feb; 66(2):125-39. PubMed ID: 15036868
[TBL] [Abstract][Full Text] [Related]
60. Characterization of cholinesterases in the damselfish Sergeant major (Abudefduf saxatilis).
Rodríguez-Fuentes G; Soto M; Luna-Ramírez K
Ecotoxicol Environ Saf; 2013 Oct; 96():99-102. PubMed ID: 23886799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
